NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Stem Cell Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Stem Cell Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Stem Cell Research



New stem cell research from Columbia University described



August 25th, 2008

According to recent research from the United States, "The common premise of synthetic implants in the restoration of diseased tissues and organs is to use inert and solid materials. Here, a porous titanium implant was fabricated for the delivery of microencapsulated bioactive cues."

"Control- released transforming growth factor-beta 1 (TGF-beta 1) promoted the proliferation and migration of human mesenchymal stem cells into porous implants in vitro. At 4 wk of implantation in the rabbit humerus, control- released TGF-beta 1 from porous implants significantly increased bone- to- implant contact (BIC) by 96% and bone ingrowth by 50% over placebos. Control- released 100 ng...


Source: Stem Cell Week (2008-08-25)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login